ABVC BioPharma, Inc.

ABVC · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$192$1,076$760$864
Short-Term Investments$65$65$65$65
Receivables$0$1,422$537$1,155
Inventory$11$11$11$0
Other Curr. Assets$3,804$195$96$96
Total Curr. Assets$4,073$2,770$1,470$2,180
Property Plant & Equip (Net)$12,425$8,675$8,702$1,151
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$2,745$2,838$2,760$2,259
Tax Assets$0$0$0$0
Other NC Assets$1,934$1,958$1,944$1,950
Total NC Assets$17,104$13,471$13,406$5,360
Other Assets$0$0$0$0
Total Assets$21,176$16,241$14,876$7,540
Liabilities
Payables$0$0$0$0
Short-Term Debt$1,227$2,137$2,823$2,967
Tax Payable$6$0$0$0
Deferred Revenue$0$81$81$81
Other Curr. Liab.$5,274$4,314$3,827$3,509
Total Curr. Liab.$6,508$6,533$6,731$6,557
LT Debt$164$177$167$237
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$12$42$22$22
Total NC Liab.$176$219$189$258
Other Liabilities$0$0$0$0
Cap. Leases$0$177$167$237
Total Liabilities$6,684$6,751$6,919$6,816
Equity
Pref Stock$0$0$0$0
Common Stock$24$20$15$14
Retained Earnings-$73,295-$72,049-$69,792-$68,950
AOCI$487$1,574$475$477
Other Equity$84,842$77,469$74,706$69,685
Total Equity$12,058$7,014$5,404$1,226
Supplemental Information
Minority Interest$2,435$2,476$2,552-$502
Total Liab. & Tot. Equity$21,176$16,241$14,876$7,540
Net Debt$1,199$1,238$2,230$2,340
ABVC BioPharma, Inc. (ABVC) Financial Statements & Key Stats | AlphaPilot